By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted January 10, 2023APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 REVENUE RESULTS READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted January 3, 2023APYX MEDICAL CORPORATION EMBARKS ON INAUGURAL BRAND CAMPAIGN FOR RENUVION READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Theodoulidis, Application of J‑Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Sutton, History of power sources in endoscopic surgery READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Smith, Laparoscopic Surgical Devices: A Review of the Newest Energies and Instruments READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Nguyen, Conservative Management of Placenta Accreta Using Helium Plasma Focused Radiofrequency Energy READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Llarena, Thermal Injury to the Ovary and Uterus in a Porcine Model: A Comparison of Four Energy Sources READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Jundt, Evolving Technologies for Tissue Cutting READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Pedroso, Thermal Effect of J-Plasma® Energy in a Porcine Tissue Model READ MORE
